Glaxo (GSK), Vir Seek EUA for Intramuscular Sotrovimab in US

Published on January 14, 2022

Glaxo (GSK) and Vir are looking to get authorization for the intramuscular administration of their COVID-19 drug candidate, sotrovimab, which is currently authorized for intravenous administration.

Continue reading on website
Other news

Delta Will Give a One-Time $1,250 Payment to Employees

January 14, 2022
Delta employees should expect the payment on February 14.

Pre-Markets Down on Disappointing Retail, Imports, Q4 Earnings

January 14, 2022
Just about every highly awaited figure hitting the tape this morning amounted to a disappointment.